Teva Pharmaceutical Industries (TEVA) shares outstanding

Shares outstanding · fiscal 2025
1.16B

Teva Pharmaceutical Industries (TEVA) had 1.16B diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 2.8% higher than the 1.13B of fiscal 2024. Figures as of 18 Nov 2026, 12:40 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Shares outstanding, fiscal 2025
1.16B
Change on fiscal 2024
+2.8%
Growth, 5 years
+1.2% a year
Growth, 10 years
+3.0% a year
Highest on record
4.70Bfiscal 2016
Lowest on record
820.00Mfiscal 2008
Fiscal years on record
192007–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Teva Pharmaceutical Industries shares outstanding, in more detail

The market data feed counts 1.17B shares outstanding today.

Over the five fiscal years to 2025 the diluted share count grew at a compound 1.2% a year; over ten years the rate was 3.0% a year. Across the 19 fiscal years on record (2007–2025), the highest was 4.70B in fiscal 2016 and the lowest 820.00M in fiscal 2008.

History · 19 fiscal years

Shares outstanding by fiscal year

Teva Pharmaceutical Industries shares outstanding, year by year

Teva Pharmaceutical Industries (TEVA) shares outstanding by fiscal year
Fiscal yearShares outstandingChangeYear ended
20251.16B 2.8% up
20241.13B 1.1% up
20231.12B 0.8% up
20221.11B 0.3% up
20211.11B 1.1% up
20201.10B 0.4% up
20191.09B 6.9% up
20181.02B 0.5% up
20171.02B 78.4% down
20164.70B 444.0% up
2015864.00M 0.7% up
2014858.00M 0.9% up
2013850.00M 2.6% down
2012873.00M 2.2% down
2011893.00M 3.0% down
2010921.00M 2.8% up
2009896.00M 9.3% up
2008820.00M 1.2% down
2007830.00M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed.

How to read it

A falling count means buybacks are giving each remaining share a larger slice of the company; a rising one means owners are being diluted.

More on TEVA

Teva Pharmaceutical Industries, figure by figure

Teva Pharmaceutical Industries (TEVA) overview: price, valuation and scorecardAll health care companies by market value

Teva Pharmaceutical Industries shares outstanding: questions and answers

How many shares does Teva Pharmaceutical Industries have?

Teva Pharmaceutical Industries (TEVA) had 1.16B diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 2.8% higher than the 1.13B of fiscal 2024. The market data feed counts 1.17B shares outstanding today.

What is the growth rate of Teva Pharmaceutical Industries's diluted share count?

Over the five fiscal years to 2025 the diluted share count grew at a compound 1.2% a year; over ten years the rate was 3.0% a year.

What are the highest and lowest diluted share count figures on record for Teva Pharmaceutical Industries?

Across the 19 fiscal years on record (2007–2025), the highest was 4.70B in fiscal 2016 and the lowest 820.00M in fiscal 2008.

How is Teva Pharmaceutical Industries's diluted share count calculated?

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed. For Teva Pharmaceutical Industries it is on record here for 19 fiscal years, 2007 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Teva Pharmaceutical Industries (TEVA) shares outstanding”, data as of 18 November 2026. https://funkfolio.com/stock/TEVA/shares-outstanding

Underlying data: the company's filings with the SEC and Yahoo Finance.